Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.3034 -0.0116 (-3.68%) Streaming Delayed Price Updated: 1:41 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes May 24, 2023 Canadian clinical-stage psychedelics company Cybin Inc. (NYSE: CYBN) announced that the first group of participants have been dosed with its proprietary deuterated DMT molecule, CYB004, in an ongoing Via Benzinga Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... Via Benzinga Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released May 09, 2023 Clinical-stage biopharma company Cybin Inc. (NYSE: CYBN) has completed participant dosing on the part 2 of 3 of its Phase 1 trial assessing intravenous (IV) administration of proprietary DMT drug... Via Benzinga April Psychedelic Drug Stocks Recap: The Ups And Downs April 30, 2023 Via Talk Markets Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today April 21, 2023 Via Benzinga Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today April 20, 2023 Via Benzinga Cybin, Mind Medicine Among Top Psychedelic Movers Of Today April 19, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 18, 2023 April 18, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 17, 2023 April 17, 2023 Via Benzinga Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More April 17, 2023 Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules Via Benzinga ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today April 14, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 13, 2023 April 13, 2023 Via Benzinga EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics April 13, 2023 The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. Via Benzinga Cybin Offers Free Online Training To Facilitate Psychedelic Therapy April 12, 2023 Cybin Inc. (NYSE: CYBN), a clinical-stage biopharma company developing innovative psychedelic-based treatment options, is launching a free online facilitation training course. Via Benzinga Psychedelic Stock Gainers And Losers From April 12, 2023 April 12, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 11, 2023 April 11, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 10, 2023 April 10, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 7, 2023 April 07, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 6, 2023 April 06, 2023 Via Benzinga Compass Pathways, GH Research Among Top Psychedelic Movers Of Today April 05, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From April 4, 2023 April 04, 2023 Via Benzinga "Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD April 04, 2023 The Via Talk Markets Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today April 03, 2023 Via Benzinga Psychedelics For Major Depressive Disorder And Anxiety Disorders: Data Suggests Cybin's Deuterated Analogs Could Work April 03, 2023 Cybin Inc (NYSE: CYBN) recently provided updates on its innovative treatments for Major Depressive Disorder (MDD) and Anxiety Disorders during its Investor Day. Via Benzinga Largest Psychedelic Stocks -3.4% In March April 02, 2023 The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. Via Talk Markets Psychedelic Stock Gainers And Losers From March 31, 2023 March 31, 2023 Via Benzinga Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today March 30, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From March 29, 2023 March 29, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From March 28, 2023 March 28, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From March 27, 2023 March 27, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.